Loading provider…
Loading provider…
Hematology & Oncology Physician in Baltimore, MD
NPI: 1295091841Primary Practice Location
JOHNS HOPKINS HOSPITAL, THE
1800 Orleans St, Baltimore, MD
Primary Employer
Jhu - Oncology
hopkinsmedicine.org
HQ Phone
Get MD Neeha's Phone Numberphone_androidMobile
Get MD Neeha's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardMD State Medical License
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 99214Established patient office or other outpatient visit, 30-39 minutes | 21 | 30 |
| 2 | 99213Established patient office or other outpatient visit, typically 15 minutes | 13 | 17 |
Worth a Pound of Cure? Emerging Strategies and Challenges in Cancer Immunoprevention.
Authors: Saurav Haldar, Anirban Maitra
Journal: Cancer Prev Res (Phila)
Authors: Hemmi, Hiroaki, Zaidi, Neeha, Wang, Bei, Matos, Ines, Fiorese, Christopher, Lubkin, Ashira, Zbytnuik, Lori, Suda, Koji, Zhang, Kenneth, Noda, Masaki, Kaisho, Tsuneyasu, Steinman, Ralph M, Idoyaga, Juliana
Journal: J Immunol
Publication Date: 2011-12-30
Lead Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Collaborators: Bristol-Myers Squibb, National Institutes of Health (NIH), National Cancer Institute (NCI)
Intervention / Treatment: DRUG: Ipilimumab, DRUG: Nivolumab, DRUG: KRAS peptide vaccine
Lead Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Collaborators: National Cancer Institute (NCI), Stand Up To Cancer
Intervention / Treatment: DRUG: Cohort A: Patients at high risk of developing pancreatic cancer., DRUG: Cohort B: Patients must have evidence of a pancreatic cystic neoplasm